Develops extracorporeal blood purification therapies designed to reduce excessive inflammation in critically ill patients. The company’s lead technology, the Selective Cytopheretic Device (SCD), is being studied for conditions such as acute kidney injury and pediatric inflammatory disorders in inten...
5 members of Congress have disclosed 8 trades in ICU, Inc. (ICU), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 6 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-07-10 | Daniel Goldman | sell | $15K – $50K |
| 2023-03-31 | Daniel Goldman | buy | $1K – $15K |
| 2023-02-27 | Daniel Goldman | buy | $1K – $15K |
| 2018-11-19 | Greg Gianforte | sell | $1K – $15K |
| 2017-01-18 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2015-03-31 | Harold Dallas Rogers | sell | $1K – $15K |
| 2015-01-13 | Thomas MacArthur | sell | $15K – $50K |
| 2015-01-12 | Thomas MacArthur | sell | $1K – $15K |